Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00131443 · ClinicalTrials.gov registry record · Phase 2
Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine
A Phase 2 study of Basilar Migraine, sponsored by Monarch Medical Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00131443: Completed Phase 2 study of Basilar Migraine, sponsored by Monarch Medical Research.
NCT00131443 is a Phase 2 study of Basilar Migraine that has completed, run by Monarch Medical Research. The registered enrollment target is 40 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00131443, a Phase 2 study of Basilar Migraine, has completed, sponsored by Monarch Medical Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess the effectiveness and safety of topiramate in the prevention of basilar and hemiplegic migraine in children and adolescents.
Conditions Studied
Interventions
- DRUG Topiramate
Study Locations (1)
Virginia
- Monarch Medical Research - Child and Adolescent Neurology - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-02 |
| Est. Completion | 2006-08 |
| Phase | Phase 2 |
What the finished NCT00131443 record still lists
NCT00131443 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Basilar Migraine appearing as the primary indexed condition, and to 1 intervention - of which Topiramate is the first listed.
NCT00131443 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT00131443 about?
NCT00131443 is a clinical study titled "Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic Migraine". The objective of this study is to assess the effectiveness and safety of topiramate in the prevention of basilar and hemiplegic migraine in children and adolescents.
What is the current status of trial NCT00131443?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2004-02. Estimated completion is 2006-08.
What conditions does trial NCT00131443 study?
This clinical trial studies the following conditions: Basilar Migraine.
What interventions are being tested in trial NCT00131443?
The interventions under investigation include: Topiramate (DRUG).
Who is sponsoring clinical trial NCT00131443?
This trial is sponsored by Monarch Medical Research, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00131443 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00131443's enrollment target sits among peer trials
40 1362nd of 2000 higher than 542 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia